Biosenta Inc.
ZRO
CNSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 100.21% | -199.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 100.21% | -199.86% | |||
| Cost of Revenue | -50.00% | 100.00% | |||
| Gross Profit | 100.14% | -199.93% | |||
| SG&A Expenses | -12.28% | -24.86% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.17% | -25.10% | |||
| Operating Income | 48.85% | -164.98% | |||
| Income Before Tax | 19.84% | -30.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.84% | -30.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.84% | -30.90% | |||
| EBIT | 48.85% | -164.98% | |||
| EBITDA | 48.89% | -165.60% | |||
| EPS Basic | 21.34% | -17.99% | |||
| Normalized Basic EPS | 21.36% | -18.39% | |||
| EPS Diluted | 21.34% | -17.99% | |||
| Normalized Diluted EPS | 21.36% | -18.39% | |||
| Average Basic Shares Outstanding | 1.77% | 10.80% | |||
| Average Diluted Shares Outstanding | 1.77% | 10.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||